Sun Pharmaceutical Industries Limited: all 327 studies

Page 2 of 4. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.CompletedNCT07546214Phase 1
• Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to Previous TreatmentsTemporarily not availableNCT07517315
• A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne VulgarisCompletedNCT07469228Phase 1
• A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne VulgarisCompletedNCT06733402Phase 1
• A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.CompletedNCT06673654Phase 1
• A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.CompletedNCT06673641Phase 1
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.Active, not recruitingNCT06611163Phase 3
• A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne PatientsActive, not recruitingNCT06425900Phase 4
• A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.CompletedNCT06305637Phase 1
• A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne VulgarisCompletedNCT06063473Phase 1
• Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy SubjectsCompletedNCT05478772Phase 1
• Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543CompletedNCT05468749Phase 1
• Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543CompletedNCT05467722Phase 1
• Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy SubjectsCompletedNCT05467709Phase 1
• Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy VolunteersCompletedNCT05467696Phase 1
• A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.CompletedNCT05282771Early Phase 1
• A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health VolunteersCompletedNCT05192369Phase 1
• A Study Comparing Oxymetazoline 1% Cream to RHOFADECompletedNCT05148689Phase 1
• Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisActive, not recruitingNCT04991116Phase 3
• A Study in Patients With Advanced Breast CancerTerminatedNCT04942054Phase 1
• A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne VulgarisCompletedNCT04883736Early Phase 1
• A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.CompletedNCT04883593Early Phase 1
• Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult SubjectsCompletedNCT04843540Phase 1
• A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne VulgarisCompletedNCT04797793Early Phase 1
• Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult SubjectsCompletedNCT04743414Phase 1
• A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne VulgarisCompletedNCT04724473Early Phase 1
• Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% CreamCompletedNCT04358770Phase 1
• To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast CancerWithdrawnNCT04332549Phase 1
• Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne VulgarisCompletedNCT04321070Phase 1
• Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)CompletedNCT04314544Phase 3
• Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)Active, not recruitingNCT04314531Phase 3
• Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female SubjectsCompletedNCT04309643Phase 1
• Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female SubjectsCompletedNCT04242953Phase 1
• Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne VulgarisCompletedNCT04134273Phase 1
• Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male VolunteersCompletedNCT04092712Phase 1
• Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell CarcinomaCompletedNCT04066504
• A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque PsoriasisActive, not recruitingNCT03997786Phase 2/3
• Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis PatientsCompletedNCT03978208Phase 2
• A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular HypertensionWithdrawnNCT03927443Phase 3
• Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia AreataActive, not recruitingNCT03898479Phase 2/3
• To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp PsoriasisCompletedNCT03880357Phase 1
• Multiple Ascending Dose Study of CTP-692 in Healthy VolunteersCompletedNCT03880253Phase 1
• Food Effect Study of CTP-543 in Healthy VolunteersCompletedNCT03880136Phase 1
• Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy VolunteersCompletedNCT03830463Phase 1
• A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy VolunteersCompletedNCT03778320Phase 1
• To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial RosaceaCompletedNCT03689010Phase 1
• An Open-Label Study to Assess SafetyCompletedNCT03645499Phase 1
• To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and AcetaminophenCompletedNCT03567941Phase 1
• To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy VolunteersCompletedNCT03445338Phase 1
• To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne VulgarisCompletedNCT03433378Early Phase 1
• To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne VulgarisCompletedNCT03427554Early Phase 1
• Bioavailability Study of K0706 in Healthy SubjectsCompletedNCT03316820Phase 1
• Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque PsoriasisWithdrawnNCT03298581Phase 2
• To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy SubjectsCompletedNCT03291418Phase 1/2
• A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%CompletedNCT03257943Phase 1
• Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic DermatitisTerminatedNCT03245385Phase 2
• Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy SubjectsCompletedNCT03220633Phase 1
• Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersActive, not recruitingNCT03212404Phase 1
• Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT03132194Phase 1
• Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast CancerCompletedNCT03109249Phase 1
• To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical GelCompletedNCT03094403Phase 1
• Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian CancerCompletedNCT03055143Phase 1
• Phase 3 Study of Levulan With New Blue Light for AK on the Face or ScalpWithdrawnNCT03024060Phase 3
• Bioavailability Study of SPARC001 (Study 2) in Healthy Adult VolunteersCompletedNCT02991261Phase 1
• Bioavailability Study of SPARC001(Study 1) in Healthy Adult VolunteersCompletedNCT02991222Phase 1
• Safety and Tolerability Study of K0706 in Subjects With Parkinson's DiseaseCompletedNCT02970019Phase 1
• Open-Label Crossover Study Comparing CTP-543 to Jakafi®CompletedNCT02960945Phase 1
• Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT02929719Phase 1
• Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid TumorsCompletedNCT02926768Phase 1
• Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back PainWithdrawnNCT02887534Phase 2
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy SubjectsCompletedNCT02777008Phase 1
• Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne VulgarisCompletedNCT02709902Phase 1
• Food Effect Study of CTP-656 in Healthy Male VolunteersCompletedNCT02680249Phase 1
• Bioavailability Study of SPARC001 in Healthy Adult VolunteersCompletedNCT02618395Phase 1
• Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656CompletedNCT02599792Phase 1
• A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507WithdrawnNCT02597465Phase 3
• A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne VulgarisCompletedNCT02595034Phase 1
• A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne VulgarisCompletedNCT02578043Phase 1
• A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne VulgarisCompletedNCT02411955Phase 1
• Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne VulgarisCompletedNCT02411942Phase 1
• Multiple Ascending Dose Study in Healthy VolunteersCompletedNCT02404922Phase 1
• Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy SubjectsCompletedNCT02392702Phase 1
• Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea PedisCompletedNCT02335255Phase 1
• Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting ConditionsCompletedNCT02327247Not applicable
• Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed ConditionsCompletedNCT02312609Not applicable
• Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fasting ConditionsCompletedNCT02312297Not applicable
• Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed ConditionsCompletedNCT02311530Not applicable
• Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed ConditionsCompletedNCT02306902Not applicable
• Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting ConditionsCompletedNCT02306889Not applicable
• A Safety and Tolerability Study of CTP-730 in Healthy VolunteersCompletedNCT02239081Phase 1
• A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and PharmacodynamicsCompletedNCT02215499Phase 1
• Twelve Month Follow-Up of CP0108CompletedNCT02209012
• Bioequivalence Study of Valsartan 320mg Tablets Under Fed ConditionsCompletedNCT02197494Not applicable
• Bioequivalence Study of Valsartan 320mg Tablets Under Fasting ConditionsCompletedNCT02197442Not applicable
• Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast CancerTerminatedNCT02136927Phase 1
• Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea PedisCompletedNCT02132260Phase 1
• Bio-equivalence Study Between SAPHRIS and AsenapineCompletedNCT01948024Phase 1
• A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)WithdrawnNCT01936688Phase 3
• A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.CompletedNCT01876550Phase 1
• Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.CompletedNCT01788007Phase 1

← Sun Pharmaceutical Industries Limited overview and focus areas